🔓 Unlock the full profile of Mark Kay (Stanford University School Of Medicine), including verified contact details, financial insights, and professional associations.
See Mark Kay Full ProfileBelow are the ✅ Verified Contact Details to help you connect directly:
Email: mar*****@sta******.com
Mobile: 73487*****
Estimated Net Worth 💰 : ₹0 – ₹500+ Cr (approx. $0 – $60M)
Key Insights You Should Know About This Individual
- Mark Kay is a prominent figure at Stanford University School of Medicine, serving as the Founder of the Scientific Advisory Board (SAB) and Board of Directors (BOD).
- As a Professor at Stanford University since 1998, Mark Kay has contributed significantly to research in the fields of genetics and molecular biology.
- Involved as a Scientific Founder and SAB member at Voyager Therapeutics, starting in January 2014, enhancing the company’s commitment to developing transformative gene therapies.
- Founded LogicBio Therapeutics in November 2015, playing a key role in advancing the company’s mission to revolutionize gene therapy.
- Mark Kay has held academic positions also at the University of Washington as an Associate Professor from 1993 until 1998, contributing to foundational research in the area of genetics.
- During tenure at Stanford, Mark Kay has actively engaged in educational programs, impacting the training and development of upcoming professionals in medicine and science.
- Participation in multiple startup ventures demonstrates a commitment to translating academic research into practical applications in the biotechnology sector.
- Mark Kay’s work has been characterized by a strong focus on advancing gene therapy, which holds significant potential for treating genetic disorders.
- At the Stanford University School of Medicine, Mark Kay continues to foster collaborations and initiatives that bridge the gap between scientific research and clinical practice.